About Us

VUZE Medical was incorporated in 2017 in Israel and is financed privately.  Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaveric surgeries (2019-2020), a first US Patent (2020, with six more since), first European and Asian patents (2021), FDA 510(k) submission (2021), successful first-in-human surgery (late 2021), FDA 510(k) clearance for minimally-invasive thoracolumbar fixation and augmentation  (2022), the completion of a highly-successful twenty-patient clinical trial (early 2023) and cadaveric proofs of concept for pain therapy and open surgery (mid 2023).